371 related articles for article (PubMed ID: 19059417)
1. Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation.
Robin G; Chappell K; Stoermer MJ; Hu SH; Young PR; Fairlie DP; Martin JL
J Mol Biol; 2009 Feb; 385(5):1568-77. PubMed ID: 19059417
[TBL] [Abstract][Full Text] [Related]
2. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
5. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
Stoermer MJ; Chappell KJ; Liebscher S; Jensen CM; Gan CH; Gupta PK; Xu WJ; Young PR; Fairlie DP
J Med Chem; 2008 Sep; 51(18):5714-21. PubMed ID: 18729351
[TBL] [Abstract][Full Text] [Related]
6. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
Murthy HM; Judge K; DeLucas L; Padmanabhan R
J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Protein Expr Purif; 2007 May; 53(1):87-96. PubMed ID: 17174105
[TBL] [Abstract][Full Text] [Related]
9. NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease.
Su XC; Ozawa K; Yagi H; Lim SP; Wen D; Ekonomiuk D; Huang D; Keller TH; Sonntag S; Caflisch A; Vasudevan SG; Otting G
FEBS J; 2009 Aug; 276(15):4244-55. PubMed ID: 19583774
[TBL] [Abstract][Full Text] [Related]
10. West Nile Virus NS2B/NS3 protease as an antiviral target.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.
Nall TA; Chappell KJ; Stoermer MJ; Fang NX; Tyndall JD; Young PR; Fairlie DP
J Biol Chem; 2004 Nov; 279(47):48535-42. PubMed ID: 15322074
[TBL] [Abstract][Full Text] [Related]
12. A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides.
Ang MJ; Li Z; Lim HA; Ng FM; Then SW; Wee JL; Joy J; Hill J; Chia CS
Peptides; 2014 Feb; 52():49-52. PubMed ID: 24333681
[TBL] [Abstract][Full Text] [Related]
13. NMR analysis of the dynamic exchange of the NS2B cofactor between open and closed conformations of the West Nile virus NS2B-NS3 protease.
Su XC; Ozawa K; Qi R; Vasudevan SG; Lim SP; Otting G
PLoS Negl Trop Dis; 2009 Dec; 3(12):e561. PubMed ID: 19997625
[TBL] [Abstract][Full Text] [Related]
14. Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.
Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Otting G; Huang D; Caflisch A
J Med Chem; 2009 Aug; 52(15):4860-8. PubMed ID: 19572550
[TBL] [Abstract][Full Text] [Related]
15. West Nile Virus (WNV) protease and membrane interactions revealed by NMR spectroscopy.
Gayen S; Chen AS; Huang Q; Kang C
Biochem Biophys Res Commun; 2012 Jul; 423(4):799-804. PubMed ID: 22713461
[TBL] [Abstract][Full Text] [Related]
16. Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR.
Kang C; Gayen S; Wang W; Severin R; Chen AS; Lim HA; Chia CS; Schüller A; Doan DN; Poulsen A; Hill J; Vasudevan SG; Keller TH
Antiviral Res; 2013 Feb; 97(2):137-44. PubMed ID: 23211132
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
De Francesco R; Pessi A; Steinkühler C
Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic flexibility of West Nile virus protease in solution characterized using small-angle X-ray scattering.
Garces AP; Watowich SJ
Biochemistry; 2013 Oct; 52(39):6856-65. PubMed ID: 24015950
[TBL] [Abstract][Full Text] [Related]
19. Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease.
Lin CW; Huang HD; Shiu SY; Chen WJ; Tsai MH; Huang SH; Wan L; Lin YJ
Virus Res; 2007 Jul; 127(1):88-94. PubMed ID: 17467838
[TBL] [Abstract][Full Text] [Related]
20. The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase.
Chernov AV; Shiryaev SA; Aleshin AE; Ratnikov BI; Smith JW; Liddington RC; Strongin AY
J Biol Chem; 2008 Jun; 283(25):17270-8. PubMed ID: 18442976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
